Eric D. Wieben
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Molecular Biology top 2%
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
Papers in
-
- RNA Research and Splicing 18
- RNA and protein synthesis mechanisms 16
- RNA modifications and cancer 9
-
- Glaucoma and retinal disorders 7
- Co-authors
- Bruce W. EckloffRichard M. WeinshilboumThoru PedersonSteven J. MadoreJaroslav BendlJiřı́ DamborskýJaroslav ZendulkaJan Štourač
- Journals
- Journal of Biological Chemistry (9 papers)Investigative Ophthalmology & Visual Science (8 papers)PLoS ONE (5 papers)Biology of Reproduction (4 papers)Journal of Neurochemistry (4 papers)
- Partner nations
- United StatesTürkiyeUnited Kingdom
In The Last Decade
Eric D. Wieben
109 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Pharmacology 371
- Molecular Biology 2.9k
- Ophthalmology 308
- Genetics 780
- Oncology 741
Countries citing papers authored by Eric D. Wieben
This map shows the geographic impact of Eric D. Wieben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Wieben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Wieben more than expected).
Fields of papers citing papers by Eric D. Wieben
This network shows the impact of papers produced by Eric D. Wieben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Wieben. The network helps show where Eric D. Wieben may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric D. Wieben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2021 | 10 | |
| 4 | 2018 | 24 | |
| 5 | 2017 | 64 | |
| 6 | 2015 | 106 | |
| 7 | PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations Hit paper breakdown → | 2014 | 604 |
| 8 | 2013 | 208 | |
| 9 | 2010 | 197 | |
| 10 | 2010 | 92 | |
| 11 | 2008 | 64 | |
| 12 | 2008 | 89 | |
| 13 | 2007 | 18 | |
| 14 | 2006 | 134 | |
| 15 | 2002 | 72 | |
| 16 | 2002 | 40 | |
| 17 | 2001 | 30 | |
| 18 | 1995 | 38 | |
| 19 | 1995 | 2 | |
| 20 | 1988 | 35 |
About Eric D. Wieben
Eric D. Wieben is a scholar working on Molecular Biology, Ophthalmology, Reproductive Medicine, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 109 papers that have together received 5.4k indexed citations. Recurring topics across this work include RNA Research and Splicing (18 papers), RNA and protein synthesis mechanisms (16 papers), Corneal surgery and disorders (14 papers), RNA modifications and cancer (9 papers), Glaucoma and retinal disorders (7 papers), Sperm and Testicular Function (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Pharmacology (371 citations), Molecular Biology (2.9k citations), Ophthalmology (308 citations), Genetics (780 citations) and Oncology (741 citations). Eric D. Wieben has collaborated with scholars based in United States, Türkiye and United Kingdom. Frequent co-authors include Bruce W. Eckloff, Richard M. Weinshilboum, Thoru Pederson, Steven J. Madore, Jaroslav Bendl, Jiřı́ Damborský, Jaroslav Zendulka, Jan Štourač, Jan Brezovský and Keith H. Baratz. Their work appears in journals such as Journal of Biological Chemistry, Investigative Ophthalmology & Visual Science, PLoS ONE, Biology of Reproduction and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.